182 related articles for article (PubMed ID: 24912918)
1. Negative regulation of DAB2IP by Akt and SCFFbw7 pathways.
Dai X; North BJ; Inuzuka H
Oncotarget; 2014 May; 5(10):3307-15. PubMed ID: 24912918
[TBL] [Abstract][Full Text] [Related]
2. Smurf1 regulation of DAB2IP controls cell proliferation and migration.
Li X; Dai X; Wan L; Inuzuka H; Sun L; North BJ
Oncotarget; 2016 May; 7(18):26057-69. PubMed ID: 27036023
[TBL] [Abstract][Full Text] [Related]
3. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
4. Deletion of SMURF 1 represses ovarian cancer invasion and EMT by modulating the DAB2IP/AKT/Skp2 feedback loop.
Fan X; Wang Y; Fan J; Chen R
J Cell Biochem; 2019 Jun; 120(6):10643-10651. PubMed ID: 30672020
[TBL] [Abstract][Full Text] [Related]
5. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells.
Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
[TBL] [Abstract][Full Text] [Related]
6. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.
Xie D; Gore C; Zhou J; Pong RC; Zhang H; Yu L; Vessella RL; Min W; Hsieh JT
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19878-83. PubMed ID: 19903888
[TBL] [Abstract][Full Text] [Related]
7. DAB2IP in cancer.
Liu L; Xu C; Hsieh JT; Gong J; Xie D
Oncotarget; 2016 Jan; 7(4):3766-76. PubMed ID: 26658103
[TBL] [Abstract][Full Text] [Related]
8. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
[TBL] [Abstract][Full Text] [Related]
9. Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.
Bellazzo A; Di Minin G; Collavin L
Cell Death Differ; 2017 Jan; 24(1):15-25. PubMed ID: 27858941
[TBL] [Abstract][Full Text] [Related]
10. DAB2IP stabilizes p27
Zhou J; Deng Z; Pei X; Lai J; Qu W
Funct Integr Genomics; 2023 Oct; 23(4):326. PubMed ID: 37880458
[TBL] [Abstract][Full Text] [Related]
11. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
12. The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.
Wang J; Zhu X; Hu J; He G; Li X; Wu P; Ren X; Wang F; Liao W; Liang L; Ding Y
Oncotarget; 2015 Sep; 6(29):27427-39. PubMed ID: 26336990
[TBL] [Abstract][Full Text] [Related]
13. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.
Ni QF; Zhang Y; Yu JW; Hua RH; Wang QH; Zhu JW
Cell Prolif; 2020 Jan; 53(1):e12630. PubMed ID: 31713929
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
[TBL] [Abstract][Full Text] [Related]
15. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB.
Min J; Zaslavsky A; Fedele G; McLaughlin SK; Reczek EE; De Raedt T; Guney I; Strochlic DE; Macconaill LE; Beroukhim R; Bronson RT; Ryeom S; Hahn WC; Loda M; Cichowski K
Nat Med; 2010 Mar; 16(3):286-94. PubMed ID: 20154697
[TBL] [Abstract][Full Text] [Related]
16. DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.
Yun EJ; Baek ST; Xie D; Tseng SF; Dobin T; Hernandez E; Zhou J; Zhang L; Yang J; Sun H; Xiao G; He D; Kittler R; Hsieh JT
Oncogene; 2015 May; 34(21):2741-52. PubMed ID: 25043300
[TBL] [Abstract][Full Text] [Related]
17. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
[TBL] [Abstract][Full Text] [Related]
18. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
[TBL] [Abstract][Full Text] [Related]
19. Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival.
Jou YC; Tsai YS; Chen SY; Hsieh HY; Tsai HT; Tzai TS
Virchows Arch; 2016 Jun; 468(6):733-40. PubMed ID: 27003158
[TBL] [Abstract][Full Text] [Related]
20. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]